Latest Bladder Cancer News
An interview with David J. McConkey, PhD
The timing of office visits and telephone calls helped identify a patient at risk for readmission post-radical cystectomy.
Recommendations for diagnosing and managing non-muscle invasive bladder cancer promise to allow for more individualized patient care.
Shorter operating time is one advantage of cutaneous ureterostomy with a single stoma.
Median time to progression or drug discontinuation was 6.6 months in patients with specific genetic alterations, compared with 1.4 months in other patients.
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone.
The guidelines were assessed for developmental rigor, and the ASCO endorsed all but one of the guidelines.
Vietnam veterans have an increased risk of bladder cancer and hypothyroidism due to exposure to Agent Orange.
Current smoking is independently associated with a greater than 2-fold increased odds of hospital readmission after radical cystectomy.
The more risk factors patients have, the greater their risk of serious perioperative complications.
Patients with venous thromboembolism tended to die earlier from their bladder cancer.
Exclusive rosiglitazone use is associated with 3-fold increased odds of bladder cancer.
The likelihood of being diagnosed with the malignancy was 37% lower in men who used the 5ɑ-reductase inhibitor than those who did.
Particularly among those who undergo major abdominal surgery.
Placebo group had significant hearing loss at one month at both 2,000 HZ and 8,000 HZ.
In contrast, type 2 diabetes is associated with increased risks of bladder, kidney, liver, and other malignancies.
Bladder Cancer Videos
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)